Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Bone Marrow Transplant Market – Insights

Bone marrow is a soft vascular tissue present in the interior of long bones. It consists of two types of stem cells: hematopoietic and mesenchymal stem cells. Bone marrow is primarily responsible for hematopoiesis (formation of blood cells), production of lymphocytes, and storage of fats.

The global bone marrow transplant market is estimated to account for US$ 13,750.7 Mn in terms of value and 121,661 procedures in terms of volume by the end of 2027.

Global Bone Marrow Transplant Market: Drivers

Increasing prevalence of blood cancer and other blood-related diseases is expected to boost growth of the global bone marrow transplant market over the forecast period. For instance, according to Leukemia and Lymphoma Society, one person in the U.S. is diagnosed with a blood cancer around every 3 minutes and 176,200 people in the country are expected to be diagnosed with leukemia, lymphoma or myeloma in 2019.

Moreover, increasing development in stem cell cryopreservation is also expected to contribute to growth of the market over the forecast period. For instance, in November 2019, in the study ‘Determination of the Membrane Transport Properties of Jurkat Cells with a Microfluidic Device’ researchers from Harbin Institute of Technology, developed a comprehensive process for determination of membrane transport properties of Jurkat cell, an immortalized line of human acute lymphocyte leukemia cells that is widely used in the study of adoptive cell therapy.

Europe region held dominant position in the global bone marrow transplant market in 2018, accounting for 58.5% share in terms of value, followed by North America.

Bone Marrow Transplant  | Coherent Market Insights

Global Bone Marrow Transplant Market: Restraints

Lack of reimbursement policies for organ transplantation procedure in emerging economies is expected to hinder growth of the global bone marrow transplant market.

Moreover, high cost of bone marrow transplant is also expected to hamper the market growth. The cost of the transplant in Europe and U.S. ranges from US$ 30,000 to US$ 88,000 for a single autologous transplantation to US$ 200,000 or more for a matched unrelated myeloablative allogeneic procedure.

Leukemia treatment type segment in the global bone marrow transplant market was valued at US$ 2,382.6 Mn in 2018 and is expected to reach US$ 3,260.5 Mn by 2027 at a CAGR of 3.5% during the forecast period.

Market Trends/Key Takeaways

Increasing R&D in stem cell therapy is expected to boost growth of the market. For instance, in December 2019, researchers from ?azan Federal University, Russia, reported that application of adipose tissue combined with fibrin matrix during the subacute period in rats offers significantly higher post-traumatic regeneration compared to similar applications of allogeneic mesenchymal stem cells derived from bone marrow or dental pulp embedded in fibrin matrix.

Increasing adoption of half-matched transplant option is also expected to boost growth of the market. In an allogeneic transplant, a patient’s human leukocyte antigen (HLA) tissue type is matched with that of the donor. Patients who do not have a HLA-matched related or unrelated donor can opt for a partially matched or haploidentical related donor.

Global Bone Marrow Transplant Market: Competitive Landscape

Major players operating in the global bone marrow transplant market include, Lonza Group Ltd., Merck Millipore Corporation, Sanofi-Aventis LLC, AllCells LLC, STEMCELL Technologies, and American Type Culture Collection (ATCC) Inc.

Key players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio. For instance, in November 2019, Lonza Group Ltd. partnered with Cryoport, Inc. in the cell and gene therapy field and across Lonza's 'vein-to-vein' delivery network.

The market is also witnessing entry of new players. For instance, in December 2019, Jasper Therapeutics, Inc. announced the launch of the company with a US$ 35 million total Series A financing. The company is focused on development of its lead product candidate, JSP191 that is designed to replace or reduce the toxicity of chemotherapy and radiation therapy as a conditioning regimen to prepare patients for hematopoietic cell transplant.

Bone marrow transplant is the replacement of damaged cells with healthy stem cells and helps human body to produce optimum levels of white blood cells, platelets, or red blood cells to avoid infections, bleeding disorders, and others. Bone marrow constitutes of blood forming stem cells known as hematopoietic stem cells (HSCs). According to the Center for International Blood & Marrow Transplant Research (CIBMTR) reports 22,863 HCTs (Hematopoietic Cell Transplantation) performed in the U.S. in 2017

Key features of the study:

  • This report provides in-depth analysis of the Bone Marrow Transplant market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Bone Marrow Transplant market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Lonza Group Ltd., Merck Millipore Corporation, Sanofi-Aventis LLC, AllCells LLC, STEMCELL Technologies, and American Type Culture Collection (ATCC) Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Bone Marrow Transplant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Bone Marrow Transplant market

Detailed Segmentation:

  • None Marrow Transplant Market, By Treatment Type:
    • Leukemia
    • Lymphoma
    • Myeloma
    • Myelodysplastic Syndrome
    • Myeloproliferative neoplasms
    • Aplastic Anemia
    • Solid Tumors
    • Sickle cell anemia
    • Thalassemia
    • Others
  • None Marrow Transplant Market, By End User:
    • Hospitals
    • Multi-Specialty Clinics
    • Ambulatory Surgical Centers
  • None Marrow Transplant Market, By Region:
    • North America
      • By Treatment Type:
        • Leukemia
        • Lymphoma
        • Myeloma
        • Myelodysplastic Syndrome
        • Myeloproliferative neoplasms
        • Aplastic Anemia
        • Solid Tumors
        • Sickle cell anemia
        • Thalassemia
        • Others
      • By End User
        • Hospitals
        • Multi-Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Treatment Type:
        • Leukemia
        • Lymphoma
        • Myeloma
        • Myelodysplastic Syndrome
        • Myeloproliferative neoplasms
        • Aplastic Anemia
        • Solid Tumors
        • Sickle cell anemia
        • Thalassemia
        • Others
      • By End User
        • Hospitals
        • Multi-Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Treatment Type:
        • Leukemia
        • Lymphoma
        • Myeloma
        • Myelodysplastic Syndrome
        • Myeloproliferative neoplasms
        • Aplastic Anemia
        • Solid Tumors
        • Sickle cell anemia
        • Thalassemia
        • Others
      • By End User
        • Hospitals
        • Multi-Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Treatment Type:
        • Leukemia
        • Lymphoma
        • Myeloma
        • Myelodysplastic Syndrome
        • Myeloproliferative neoplasms
        • Aplastic Anemia
        • Solid Tumors
        • Sickle cell anemia
        • Thalassemia
        • Others
      • By End User
        • Hospitals
        • Multi-Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Treatment Type:
        • Leukemia
        • Lymphoma
        • Myeloma
        • Myelodysplastic Syndrome
        • Myeloproliferative neoplasms
        • Aplastic Anemia
        • Solid Tumors
        • Sickle cell anemia
        • Thalassemia
        • Others
      • By End User
        • Hospitals
        • Multi-Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Treatment Type:
        • Leukemia
        • Lymphoma
        • Myeloma
        • Myelodysplastic Syndrome
        • Myeloproliferative neoplasms
        • Aplastic Anemia
        • Solid Tumors
        • Sickle cell anemia
        • Thalassemia
        • Others
      • By End User
        • Hospitals
        • Multi-Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Lonza Group Ltd.*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Merck Millipore Corporation
    • Sanofi-Aventis LLC
    • AllCells LLC
    • STEMCELL Technologies
    • American Type Culture Collection (ATCC) Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Treatment Type
      • Market Snippet, By Application
      • Market Snippet, By Region Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Technological Advancements
    • Key Highlights
    • Epidemiology
    • Regulatory Scenario
    • PEST Analysis
    • Mergers and Acquisitions
  4. Global Bone Marrow Transplant Market, By Treatment Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Leukemia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Number of Procedures)
    • Lymphoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Number of Procedures)
    • Myeloma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Number of Procedures)
    • Myelodysplastic Syndrome
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Number of Procedures)
    • Myeloproliferative neoplasms
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Number of Procedures)
    • Aplastic Anemia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Number of Procedures)
    • Solid Tumors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Number of Procedures)
    • Sickle cell anemia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Number of Procedures)
    • Thalassemia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Number of Procedures)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Number of Procedures
  5. Global Bone Marrow Transplant Market, By End User, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Multi-Specialty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Bone Marrow Transplant Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Treatment Type, 2016 – 2027, (US$ Million and Number of Procedures)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Treatment Type, 2016 – 2027, (US$ Million and Number of Procedures)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Treatment Type, 2016 – 2027, (US$ Million and Number of Procedures)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Treatment Type, 2016 – 2027, (US$ Million and Number of Procedures)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Treatment Type, 2016 – 2027, (US$ Million and Number of Procedures)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Treatment Type, 2016 – 2027, (US$ Million and Number of Procedures)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Company Profiles
      • Lonza Group Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck Millipore Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sanofi-Aventis LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AllCells LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  STEMCELL Technologies
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • American Type Culture Collection (ATCC) Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 42 market data tables and 44 figures on “Bone Marrow Transplant Market - Global forecast to 2027”.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner